QGenda Simplifies Credentialing at MyMichigan Health to Boost Efficiency and Patient Access QGenda, a top provider of healthcare workforce management solutions, has announced that MyMichigan Health has adopted QGenda Credentialing to enhance operational efficiency, reduce credentialing time, and improve the…
DT Research Expands Medical Computing Line with DT514 All-in-One PCs DT Research, a leader in designing and manufacturing specialized computing solutions for vertical markets, has unveiled its DT514 series of All-in-One (AIO) medical computers. These devices are purpose-built to address…
ImmunoPrecise Antibodies Announces Restructuring of Management Team ImmunoPrecise Antibodies (IPA) (NASDAQ: IPA), an AI-driven biotherapeutics discovery and technology company, is excited to share several important leadership changes. Kamil Isaev has been appointed to the Company’s Board of Directors, and Joseph…
C2N Diagnostics’ PrecivityAD2™ Blood Test Gets MHRA Certification in the UK C2N Diagnostics, LLC, a leader in advanced brain health diagnostic testing, today announced that its PrecivityAD2™ blood test has received medical device registration from the United Kingdom’s Medicines and…
Seqfirst-neo Study Highlights Impact of Genomic Testing in NICU, Exposing Gaps in Protocols GeneDx (Nasdaq: WGS), a leading provider of genomic insights aimed at improving health outcomes, announced today that the American Journal of Human Genetics has published peer-reviewed research…
Memphis Extends Talkspace Partnership, Expands Mental Health Services to Dependents 13+ Talkspace (NASDAQ: TALK), a leading online behavioral healthcare company, announced it will continue supporting the City of Memphis for a fifth consecutive year by providing free virtual therapy and…
Scale Biosciences Unveils Five Single Cell Profiling Products for Scalable RNA Studies Scale Biosciences (Scale Bio™), a leader in scalable single cell analysis, has announced the launch of its QuantumScale Single Cell RNA kits. These next-generation products are designed to…
Median Technologies to Present eyonis™ LCS AI Software for Lung Cancer Screening at ECR Median Technologies, a leader in artificial intelligence (AI)-powered software for early cancer diagnostics, has announced its participation in the 2025 European Congress of Radiology (ECR) in…
Healx Doses First Patient in Phase 2 Trial of HLX-1502 for Neurofibromatosis Type 1 Healx, a clinical-stage biotech company utilizing AI to advance treatments for rare diseases, has announced that the first patient has been dosed in its Phase 2…
PepGen Announces Positive Results from FREEDOM-DM1 Trial in DM1 Patients PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company focused on advancing next-generation oligonucleotide therapies, recently announced promising early results from the ongoing FREEDOM-DM1 Phase 1 trial. The trial is investigating…
Seraph 100 May Reduce Tumor Particles in Blood Samples from Pancreatic Cancer Patients A recent laboratory study has explored the potential therapeutic benefits of blood purification for patients with metastatic pancreatic ductal adenocarcinoma (PDAC), one of the most aggressive and…
Bruker Enhances Single-Cell Proteomics and Immunopeptidomics with New Software at US HUPO At the 21st Annual US HUPO Conference, Bruker Corporation (Nasdaq: BRKR) unveiled significant advancements in 4D-Proteomics™ performance, along with new software and applications aimed at providing deeper biological…